DANDRITE

The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

FIMM

The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

MIMS

The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

NCMM

Centre for Molecular Medicine Norway (NCMM) is the Norwegian node of the Nordic EMBL Partnership. NCMM conducts molecular medicine & biotech research and works translate these findings into clinical practice.

Latest News

2020.07.11 | People

Welcome to: Dr. Sebastian Waszak

Dr. Waszak joined NCMM in March 2020 as head of the Computational Oncology group.Dr Waszak completed his postdoc at EMBL Heidelberg in the group of Jan Korbel. In this article, he describes his research into precision medicine for young people with cancer, the role that rare genetic disorders can play when it comes to cancer treatment, and what…

Dr Paula Lindner. Photo: UiO
Dr. Nikolai Engedal. Photo: UiO
Dr. Poul Nissen. Photo: AU photo

2020.07.02 | Research news

Paula Lindner: Joint PhD student, DANDRITE and NCMM

Paula Lindner defended her PhD on 9 June 2020. Her PhD was a joint project between NCMM, Faculty of Medicine, University of Oslo, and DANDRITE (the Danish Research Institute of Translational Neuroscience, Aarhus), Aarhus University.

Antibiotics bind to and corrupt the functioning of crucial elements of bacterial cells, such as the ribosome that synthesises proteins or RNA polymerase that reads genes to generate mRNA. To counter the action of antibiotics, bacteria have evolved numerous dedicated mechanisms of resistance. Commonly, these resistance mechanisms act by either destroying the antibiotic, pumping it out of the cell or permanently modifying the molecular target so it becomes immune to the antibiotic, e.g. by post-translational modification such as methylation.

2020.06.26 | Research news

High profile review publication on antibiotic resistance from the Hauryliuk and Atkinson labs, MIMS

In this review, published in the influential journal Nature Reviews Microbiology, Umeå researchers Vasili Hauryliuk (also affiliated with Tartu University, Estonia) and Gemma C. Atkinson, together with their collaborators Daniel N. Wilson (University of Hamburg, Germany) and Alex J. O’Neill (University of Leeds, UK) discuss an important and…

2020.06.03 | People

Welcome to Hanna M. Ollila

Dr. Hanna M. Ollila is a FIMM-EMBL Group Leader at the Institute for Molecular Medicine Finland (FIMM), based at the University of Helsinki. Hanna specializes in the genetics of sleep and brain autoimmunity. In this interview, Hanna sheds some light on her field of research and elaborates on future plans for her newly established research group.

Showing results 1 to 4 of 53

1 2 3 4 5 6 7 8 9 10 Next

Upcoming Partnership Events

Fri 18 Sep: 16:00-17:00 | Zoom
DANDRITE Virtual Lecture Series: Kenneth Harris
Kenneth Harris is Professor at the Department of Neuromuscular Diseases, University College London. The title of his lecture is: “Learning orthogonalizes visual cortical population codes”.
Tue 22 Sep: 09:00-16:00 | Virtual meeting
10th annual Nordic EMBL Partnership Meeting
The 2020 Nordic EMBL Partnership meeting, hosted by MIMS, Umeå, will take place online.
Fri 02 Oct: 13:00-14:00 | Aarhus, Denmark
Joint DANDRITE-Biomedicine/ Neuroscience Lecture
Joint DANDRITE-Biomedicine/Neuroscience Lecture with Nobel laureate in Psychology or medicine 2014 Dr Edvard Ingjald Moser. Dr Edvard Ingjald Moser will give a talk on "Space and time: Internal dynamics of the brain's entorhinal cortex"

Follow us!

Follow @NordicEMBL

Nordic EMBL Partnership for Molecular Medicine

The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.